Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Supplementation for Supraventricular Arrhythmias
NCT02837328Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Mar 2017
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of magnesium in Supraventricular arrhythmia (SVA), sponsored by University of Minnesota. Started Mar 2017; status: completed.
02
Drugs
magnesium
03
Conditions
Supraventricular arrhythmia (SVA)
Beyond the preview
Go deeper on NCT02837328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02837328.